No Data
No Data
DELFI Diagnostics CTO Recognized Among 2025 Most Influential Women in Bay Area Business
Delfi's (SGX:P34) Dividend Is Being Reduced To $0.0157
DELFI Diagnostics to Present Early Detection and Advanced Cancer Monitoring Technology Updates at AACR Annual Meeting
Delfi Limited (SGX:P34) Stock Most Popular Amongst Private Companies Who Own 51%, While Individual Investors Hold 33%
Delfi: Annual Reports and Related Documents
Delfi Target Price Lowered to S$0.82 From S$0.86 by UOB Kay Hian >P34.SG